US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist
  • 8.480
  • -0.100-1.17%
Close Jun 14 16:00 ET
  • 8.480
  • 0.0000.00%
Post 16:07 ET
412.41MMarket Cap-9528P/E (TTM)

Theravance Biopharma Key Stats

Theravance Biopharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 13, 2024

Revenue(YoY)

14.50M

+39.22%
EPS(YoY)

-0.24

+31.43%

Strong Buy

May 31, 2024

Theravance Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 16.266M--
--2024/Q2-- / 15.307M--
May 13, 20242024/Q114.503M / 13.950M--
Feb 26, 20242023/Q417.565M / 17.575M--
Nov 7, 20232023/Q315.693M / 15.052M--
Aug 7, 20232023/Q213.749M / 15.421M--
May 8, 20232023/Q110.417M / 13.703M--
Feb 27, 20232022/Q414.649M / 15.729M--
Nov 7, 20222022/Q312.451M / 11.810M--
Aug 4, 20222022/Q211.050M / 11.803M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 16.266M--
--2024/Q2-- / 15.307M--
May 13, 20242024/Q114.503M / 13.950M--
Feb 26, 20242023/Q417.565M / 17.575M--
Nov 7, 20232023/Q315.693M / 15.052M--
Aug 7, 20232023/Q213.749M / 15.421M--
May 8, 20232023/Q110.417M / 13.703M--
Feb 27, 20232022/Q414.649M / 15.729M--
Nov 7, 20222022/Q312.451M / 11.810M--
Aug 4, 20222022/Q211.050M / 11.803M--

Unlock Free Earnings Estimates

Theravance Biopharma Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 31, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg